Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
This study investigates the poor reversibility of salmon calcitonin (sCT) binding to rat and human calcitonin receptors. Efficacy of CT and analogue peptides in (125)I-sCT binding competition and cAMP assays was compared with the dissociation kinetics of (125)I-labelled peptides. Assessment was performed on cells stably expressing either rat or human calcitonin receptors. Dissociation kinetics of the antagonists, sCT(8-32) and AC512, revealed that binding was rapidly and completely reversible at the receptors, despite high affinity binding, suggesting that poor reversibility required the active conformation of the receptor. G protein coupling was not essential as the dissociation kinetics of (125)I-sCT binding to cell membranes did not significantly alter in the presence of GTP gamma S. Time course experiments established that the transition to irreversibility was slow, while the reversible component of binding appeared to involve a single population of either receptor states or binding sites. Pre-bound (125)I-human CT dissociated rapidly from the receptors, indicating that not all agonists bound irreversibly. To identify structural features of sCT that contribute to its poor reversibility, dissociation kinetics of sCT analogues with various structural modifications were examined. Increasing truncation of N-terminal residues of sCT analogues led to a corresponding increase in the rate of peptide dissociation. Salmon CT peptides which had been substituted at the N-terminus by 13-21 residues of human CT (hCT) were equipotent with sCT in binding competition and cAMP accumulation assays but exhibited a dissociation rate similar to hCT. In contrast, despite lower affinity and efficacy at the receptors, the chimeric analogue sCT(1-16)-hCT(17-32) displayed poorly reversible binding, similar to sCT. Analysis of the dissociation kinetics of sCT analogues with differing alpha-helix forming potential indicated that the ability to form alpha-helical secondary structure was an important factor in the rate of ligand dissociation. We hypothesise that poor reversibility results from a conformational change in the receptor and/or ligand and that this is dependent, at least in part, on interaction with residues constrained within the alpha-helix of the peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In structure/function studies, chimeras of sCT and hCT were made, and sCT peptides, which had the NH 2 terminus substituted by the 13-21 residues of hCT, completely dissociated from receptors, whereas combinations of sCT (1-16) and hCT (17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32) retained the irreversible binding of sCT (92).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [92]
Citations
Cites
Biochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Nicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 3×
“…of sCT, sCT analogues and sCT/hCT chimeras Synthetic sCT, sCT analogues and sCT/hCT chimeric peptides were iodinated as previously described (Nicholson et al. 1986), with 125I using 5 µg chloramine T for 10 s as oxidant, purification with the silica resin QUSO G32 (North America Silica Co.,…”
BackgroundMethodInfluentialSelf-citationGorn, A. H., Lin, H. Y., Yamin, M., Auron, P. E., Flannery, M. R., Tapp, D. R., Manning, C. A., Lodish, H. F., Krane, S. M., & Goldring, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116046 · Cited by 211 · cited 4×
“Calcitonin receptors (CTRs) have been cloned from a number of species including rat (Sexton et al. 1993) and human (Gorn et al. 1992, Kuestner et al. 1994).”
BackgroundMethodInfluentialBisello, A., Adams, A. E., Mierke, D. F., Pellegrini, M., Rosenblatt, M., Suva, L. J., & Chorev, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22498 · Cited by 181 · cited 1×
“It has been speculated that the -helical secondary structure adopted by family B G protein coupled receptor ligands may be important in orienting the ligand into phase with the binding site(s) of the receptor (Bisello et al. 1998).”
BackgroundFull Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin
Bergwitz, C., Gardella, T. J., Flannery, M. R., Potts, J. T., Kronenberg, H. M., Goldring, S. R., & Jüppner, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26469 · Cited by 169 · cited 1×
“Chimeric peptide/receptor studies between sCT and PTH and their receptors, have revealed a similar mode of ligand–receptor interaction for these peptides (Bergwitz et al. 1996).”
BackgroundCloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner, R. E., Elrod, R. D., Grant, F. J., Hagen, F. S., Kuijper, J. L., Matthewes, S. L., O'Hara, P. J., Sheppard, P. O., Stroop, S. D., & Thompson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09678-6 · Cited by 149 · cited 7×
“G protein coupling was not essential as the dissociation kinetics of 125I-sCT binding to cell membranes did not significantly alter in the presence of GTP S. Time course experiments established that the transition to irreversibility was slow, while the reversible component of binding appeared to…”
BackgroundMethodInfluentialIdentification of brain isoforms of the rat calcitonin receptor.
Sexton, P. M., Houssami, S., Hilton, J. M., O'Keeffe, L. M., Center, R. J., Gillespie, M. T., Darcy, P., & Findlay, D. M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.6.8395656 · Cited by 134 · cited 3×
“In rat, the principle receptor isoforms, C1a and C1b, differ by the absence or presence, respectively, of a 37 amino acid insert in the predicted second extracellular domain (Sexton et al. 1993).”
BackgroundSelf-citationCharacterization and regional distribution of calcitonin binding sites in the rat brain
Fischer, J. A., Sagar, S. M., & Martin, J. B. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90018-7 · Cited by 107 · cited 4×
“This is true of human or rat tissue membrane preparations ( Fischer et al. 1981, Nicholson et al. 1988b), as well as clonal cell lines of rat or human origin (Findlay et al. 1981, Chao & Forte 1983).”
BackgroundResultInfluentialOffermanns, S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.566 · Cited by 106 · cited 2×
“This is particularly true for release of intracellular calcium, presumably mediated by coupling to Gq (Offermanns et al. 1996), as no signal was seen in insert-positive receptor (Moore et al.”
BackgroundMoore, E. E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.8.959 · Cited by 104 · cited 9×
“Analysis of the function of the I1 insert demonstrates that while ligand recognition remains essentially unchanged, G protein-mediated signalling is markedly impaired (Moore et al. 1995).”
BackgroundMethodInfluentialSelf-citation
Cited by
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
“Although 125I-human CT binds reversibly to its receptor, salmon CT binds irreversibly, resulting in sustained cAMP accumulation (Fischer et al., 1981; Nicholson et al., 1987; Hilton et al., 2000).”
BackgroundSelf-citationPhase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
“Nonspecific binding was measured in the presence of 1 μM of [8-32]sCT.”
BackgroundMethodSelf-citationAmylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“This is not surprising, given that it contains portions of the salmon calcitonin sequence; salmon calcitonin is well recognized as having a slow receptor dissociation rate from receptors (Hilton et al., 2000).”
BackgroundAdvances in therapeutic peptides targeting G protein-coupled receptors
Davenport, A. P., Scully, C. C. G., de Graaf, C., Brown, A. J. H., & Maguire, J. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0062-z · Cited by 275
Dean, T., Vilardaga, J.-P., Potts, J. T., & Gardella, T. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0274 · Cited by 227
“Thus, several others of these receptors, including the receptors for calcitonin (34), CRH (17), and glucagon (35) have been shown to form a stable complex with their cognate peptide ligand in the presence of a nonhydrolyzable guanine nucleotide analog.”
Background
Metadata
- Authors
- Hilton, J., Dowton, M., Houssami, S., & Sexton, P.
- Affiliations
- The University of Melbourne (AU)
- ORCID
- Dowton, M
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2000-07-01
- Volume
- 166
- Issue
- 1
- Pages
- 213-226
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2134691383
- Cited by
- 70
- References
- 42
- Citations by year
- 2025: 3 · 2024: 1 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amylin Pharmaceuticals
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- salmon calcitonin, calcitonin receptor, ligand dissociation kinetics, receptor conformational change, N-terminal truncation, alpha-helix, G protein coupling
- MeSH terms
- Cyclic AMP, Animals, Binding, Competitive, Calcitonin, Cells, Cultured, Humans, Protein Binding, Receptors, Calcitonin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. https://app.cochat.ai/papers/10.1677/joe.0.1660213
- The paper
- Hilton, J., Dowton, M., Houssami, S., & Sexton, P. (2000). Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. Journal of Endocrinology. https://doi.org/10.1677/joe.0.1660213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.